Marino S, Petrusca DN, Bishop RT, Anderson JL, Sabol HM, Ashby C, Layer JH, Cesarano A, Davé UP, Perna F, Delgado-Calle J, Chirgwin JM, Roodman GD. Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma. haematol [Internet]. 2024May1 [cited 2024Nov.27];109(5):1501-13. Available from: https://haematologica.org/article/view/haematol.2023.283787